4.7 Review

Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review

Related references

Note: Only part of the references are listed.
Review Oncology

Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer

Jamie E. Chaft et al.

Summary: Biomarker-informed clinical trials are pushing the treatment of early-stage lung cancer beyond cytotoxic chemotherapy, with the incorporation of targeted and immunotherapies. Adjuvant osimertinib, preoperative chemoimmunotherapy, and adjuvant immunotherapy could improve outcomes for resectable lung cancer patients, and ongoing or planned studies focusing on biomarkers, immunotherapy, and targeted therapy may further enhance survival.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Plant Sciences

Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa

Fang-Yuan Zhang et al.

Summary: Emodin exhibited a novel anti-tumor mechanism by decreasing the expression levels of sPLA2-IIa and NF-kappa B pathways, thus inhibiting the proliferation of KRAS mutant cell lines in non-small-cell lung cancer (NSCLC). This suggests that emodin could potentially serve as a therapeutic target in NSCLC.

PHYTOMEDICINE (2022)

Article Oncology

Cepharanthine Regulates Autophagy via Activating the p38 Signaling Pathway in Lung Adenocarcinoma Cells

Gang Li et al.

Summary: This study found that CEP has inhibitory effects on proliferation, migration, and invasion of human lung cancer cells. It regulates autophagy by activating the p38 signaling pathway, providing a potential application in lung cancer prevention.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)

Article Plant Sciences

Andrographolide, a diterpene lactone from the Traditional Chinese Medicine Andrographis paniculate, induces senescence in human lung adenocarcinoma via p53/p21 and Skp2/p27

Junqian Zhang et al.

Summary: The study demonstrates that Andrographolide (AD) induces senescence in human lung adenocarcinoma cells via the p53/p21 and Skp2/p27 pathways, showing its potential anti-tumor effects in vitro and in vivo.

PHYTOMEDICINE (2022)

Article Biochemistry & Molecular Biology

Ajuforrestin A, an Abietane Diterpenoid from Ajuga ovalifolia var. calanthe, Induces A549 Cell Apoptosis by Targeting SHP2

Hongling Yan et al.

Summary: Compound 2 isolated from Ajuga ovalifolia var. calantha is a selective inhibitor of SHP2 activity and inhibits the proliferation and invasion of lung epithelial cancer cells by targeting the SHP2-ERK/AKT signaling pathway.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

The Role and Mechanisms of Action of Natural Compounds in the Prevention and Treatment of Cancer and Cancer Metastasis

Yunqiao Wang et al.

Summary: Cancer is a major global health concern with complex progression and metastasis mechanisms. Natural drugs have a long history in the prevention and treatment of cancer. This review analyzed high-frequency keywords from various Chinese and English databases, identifying common Chinese herbal medicines and natural compounds used for cancer prevention and treatment. The review also summarized the mechanisms of action of these active compounds in tumor-related research and highlighted recent attention on four natural compounds in anti-cancer research.

FRONTIERS IN BIOSCIENCE-LANDMARK (2022)

Article Cell Biology

Inhibitory effect of sinomenine on lung cancer cells via negative regulation of α7 nicotinic acetylcholine receptor

Shasha Bai et al.

Summary: The study showed that sinomenine inhibits the proliferation and migration abilities of lung cancer cells, increases apoptosis, and suppresses tumor growth by targeting the alpha 7 nAChR. The inhibitory effects are influenced by specific antagonists, suggesting that sinomenine may play a significant role in lung cancer treatment.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Article Oncology

Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction

Xiao-Qin Li et al.

Summary: The study found that the combination of paclitaxel and honokiol synergistically killed NSCLC cells by inducing paraptosis, characterized by cytoplasmic vacuolation. Mechanistically, proteasomal inhibition-mediated endoplasmic reticulum stress and unfolded protein responses leading to ER dilation, as well as disruption of intracellular Ca(2+) homeostasis and mitochondrial Ca(2+) overload resulting in mitochondrial dysfunction, were involved in paclitaxel/honokiol-induced paraptosis. Additionally, cellular protein protein light chain 3 (LC3) may play a significant role in paclitaxel/honokiol induced cytoplasmic vacuolation and NSCLC cell death. Therefore, the combination of honokiol and paclitaxel may present a novel strategy for the treatment of paclitaxel-resistant NSCLC.

CELLULAR ONCOLOGY (2021)

Article Oncology

Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway

Mingzhu Li et al.

Summary: This study demonstrates that emodin regulates the cell cycle of NSCLC cells through the HAS2-HA-CD44/RHAMM interaction-dependent signaling pathway.

CANCER CELL INTERNATIONAL (2021)

Review Biochemistry & Molecular Biology

Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands

Sarah Sayed Hassanein et al.

Summary: Lung cancer is a complex disease associated with gene mutations, particularly KRAS and EGFR. miRNAs play a key role in regulating EGFR crosstalk, affecting sensitivity to EGFR-TKI treatment, and can be used as diagnostic, prognostic, and therapeutic targets in NSCLC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Small-cell lung cancer

Charles M. Rudin et al.

Summary: Small-cell lung cancer is a type of lung cancer characterized by high proliferative rate, early metastasis, and poor prognosis, strongly associated with tobacco carcinogens. Most patients are diagnosed with metastatic disease, with only a small fraction having potentially curative earlier-stage disease. Genomic profiling reveals extensive chromosomal rearrangements and high mutation burden in SCLC, often involving inactivation of TP53 and RB1 tumor suppressor genes.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Biotechnology & Applied Microbiology

Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis

Jing Jin et al.

Summary: Bufalin exerts anti-tumor effects in NSCLC by modulating the circ_0046264/miR-522-3p pathway, which could be a potential functional mechanism of bufalin in NSCLC.

BIOTECHNOLOGY LETTERS (2021)

Article Oncology

Small Cell Lung Cancer, Version 2.2022

Apar Kishor P. Ganti et al.

Summary: The NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of SCLC, emphasizing the importance of systemic therapy for extensive-stage disease and promoting smoking cessation in patients.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Immunology

Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice

Rui-Lin Chen et al.

Summary: The combination of isovitexin and cisplatin showed promising effects in inhibiting proliferation and inducing apoptosis of non-small cell lung cancer cells. Isovitexin not only enhanced the antitumor activity of cisplatin against lung cancer cells, but also reduced cisplatin-induced hepatotoxicity and nephrotoxicity in mice. Additionally, isovitexin promoted immune cell activities and reduced glucose metabolism, presenting a novel strategy to enhance platinum-based chemotherapy against non-small cell lung cancer.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Oncology

Non-Small Cell Lung Cancer, Version 2.2021 Featured Updates to the NCCN Guidelines

David S. Ettinger et al.

Summary: The NCCN Guidelines for NSCLC cover all aspects of management, with recent updates focusing on targeted therapies, immunotherapies, and their respective biomarkers.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Biochemistry & Molecular Biology

Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines

Nazilah Abdul Satar et al.

Summary: This study demonstrates the potential of curcumin as a chemosensitizer for targeting cancer stem cell subpopulations in non-small cell lung cancer. Curcumin reduces cellular proliferation and inhibits self-renewal capability of lung cancer stem cells, while also regulating the stem cell niche to inhibit chemoresistance and cancer-related protein expression.

MOLECULES (2021)

Review Biology

The positive role of traditional Chinese medicine as an adjunctive therapy for cancer

Xiaoyi Zhang et al.

Summary: Traditional Chinese medicine, especially Chinese herbal medicines and acupuncture, has been used to effectively alleviate cancer symptoms and treatment-related adverse reactions, improving patients’ quality of life. Current research has focused on the efficacy of herbal medicines and acupuncture, but more rigorously designed trials are needed in the future to further validate their effectiveness.

BIOSCIENCE TRENDS (2021)

Article Chemistry, Multidisciplinary

Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition

Qiu-di Deng et al.

Summary: Triptolide derived from Tripterygium wilfordii Hook F inhibits NSCLC metastasis by targeting EMT and reducing beta-catenin expression. In animal models, triptolide suppresses tumor growth, decreases lung metastasis, suggesting its potential therapeutic effect on NSCLC metastasis.

ACTA PHARMACOLOGICA SINICA (2021)

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Cell Biology

Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5

Yufang Sun et al.

Summary: The natural product tanshinone IIA (TIIA) was found to enhance NK cell-mediated killing of non-small cell lung cancer (NSCLC) cells by up-regulating ULBP1 and DR5, indicating promising potential in cancer immunotherapy.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Article Oncology

Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism

Zhao Chen et al.

Summary: Andrographolide inhibits the proliferation of non-small cell lung cancer cells by activating the mitochondrial apoptosis pathway and reprogramming glucose metabolism. By suppressing glycolysis and promoting the gluconeogenesis pathway, Andrographolide induces apoptosis in NSCLC cells through modulation of various protein expressions.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression

Qiang Han et al.

Summary: WBP2 is highly expressed in lung cancer and correlates with clinical features and prognosis. Functional experiments demonstrate that WBP2 promotes proliferation and invasion of lung cancer cells. WBP2 inhibits Hippo pathway activity by competitively binding to WWC3 and LATS1, leading to YAP nuclear translocation.

CELL DEATH & DISEASE (2021)

Article Oncology

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

Ze-Bo Jiang et al.

Summary: The study showed that luteolin and apigenin can effectively inhibit the proliferation of KRAS-mutant lung cancer cells, reduce the expression of IFN-gamma-induced PD-L1, and induce apoptosis by suppressing STAT3 phosphorylation. Combined treatment with PD-1 blockade and apigenin/luteolin had a synergistic effect, offering a potential therapeutic strategy for NSCLC with KRAS mutations.

CANCER LETTERS (2021)

Review Biochemistry & Molecular Biology

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms

Paula Montero et al.

Summary: This review explores the activation of the JAK/STAT molecular pathway in ILDs and its impact on cellular fibrotic processes, highlighting the significant role of JAK/STAT in ILDs. It also discusses the potential therapeutic drugs targeting JAK/STAT and their application in vitro and in clinical trials.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Overcoming Chemotherapy Resistance in SCLC

Brett H. Herzog et al.

Summary: SCLC is an aggressive form of lung cancer with poor prognosis, showing initial response to platinum-based chemotherapy but developing resistance upon recurrence. Recent research findings have shed light on the mechanisms behind chemotherapy resistance in SCLC, potentially informing clinical implications.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Oncology

Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non-small cell lung cancer

Yijun Zhang et al.

Summary: The study revealed that high expression of INHBA in clinical NSCLC is associated with advanced tumor stage and poor prognosis, and it can enhance the invasive abilities of NSCLC by modulating the Hippo pathway.

MOLECULAR MEDICINE REPORTS (2021)

Review Biochemistry & Molecular Biology

MicroRNAs regulating SOX2 in cancer progression and therapy response

Sepideh Mirzaei et al.

Summary: The interaction between miRNAs and SOX2 plays a crucial role in regulating the growth, migration, and therapy response of cancer cells. In addition to miRNAs and SOX2, lncRNAs and circRNAs serve as upstream regulators in this axis. Various molecular pathways, such as NF-kappa B, TNF-alpha, and SOX17, also influence the miRNA/SOX2 axis in cancer.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)

Review Oncology

Lung cancer in China: current and prospect

Fengying Wu et al.

Summary: The current status of lung cancer in China is concerning, with distinct gene profiles and the need for treatment considerations based on drug accessibility and regional differences. Targeted therapy has made significant progress, while immunotherapy is rapidly developing. Future efforts should focus on preventive strategies and clinical trials tailored to the characteristics of lung cancer in China.

CURRENT OPINION IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments

Kuo-Shyang Jeng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Chemistry, Medicinal

Medicinal Potential of Heterocyclic Compounds from Diverse Natural Sources for the Management of Cancer

Manjinder Singh et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs

Kun-Hung Shen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Pharmacology & Pharmacy

A Novel Benzofuran Derivative Moracin N Induces Autophagy and Apoptosis Through ROS Generation in Lung Cancer

Chengcheng Gao et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Medicine, Research & Experimental

Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway

Shibo Wu et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Review Cell Biology

Hedgehog Signaling and Truncated GLI1 in Cancer

Daniel Doheny et al.

CELLS (2020)

Article Biochemistry & Molecular Biology

Effects of WSG, a polysaccharide from Ganoderma lucidum, on suppressing cell growth and mobility of lung cancer

Wei-Hung Hsu et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Article Biochemistry & Molecular Biology

Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer

Jing Duan et al.

FOOD & FUNCTION (2020)

Article Medicine, Research & Experimental

Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells

Jianfei Zhu et al.

LIFE SCIENCES (2019)

Article Pharmacology & Pharmacy

Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer

Fei Cao et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)

Article Biotechnology & Applied Microbiology

Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway

Rui Wang et al.

ONCOTARGETS AND THERAPY (2019)

Article Cell Biology

MiR-520b promotes the progression of non-small cell lung cancer through activating Hedgehog pathway

Xiaoming Liu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Review Nutrition & Dietetics

Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer

Wan Nur Baitty Wan Mohd Tajuddin et al.

NUTRIENTS (2019)

Article Oncology

Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol

Hannah E. Pearson et al.

MOLECULAR CANCER THERAPEUTICS (2018)

Review Oncology

Emerging functions of the EGFR in cancer

Sara Sigismund et al.

MOLECULAR ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Anticancer activity of polysaccharide from Glehnia littoralis on human lung cancer cell line A549

Jun Wu et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)

Article Biochemistry & Molecular Biology

Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells

Hyejin Park et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Biochemistry & Molecular Biology

Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance

Etienne Giroux-Leprieur et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Pharmacology & Pharmacy

Lico A Causes ER Stress and Apoptosis via Up-Regulating miR-144-3p in Human Lung Cancer Cell Line H292

Gang Chen et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Environmental Sciences

Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo

Shin-Hwar Wu et al.

ENVIRONMENTAL TOXICOLOGY (2017)

Article Oncology

Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation

Mingxing Zheng et al.

MOLECULAR MEDICINE REPORTS (2017)

Article Biochemistry & Molecular Biology

Licochalcone A Inhibits the Proliferation of Human Lung Cancer Cell Lines A549 and H460 by Inducing G2/M Cell Cycle Arrest and ER Stress

Chenyu Qiu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Pharmacology & Pharmacy

Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells

Lian-Xiang Luo et al.

FRONTIERS IN PHARMACOLOGY (2017)

Article Plant Sciences

Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro

An-Cheng Huang et al.

JOURNAL OF ETHNOPHARMACOLOGY (2016)

Article Public, Environmental & Occupational Health

Anti-tumor activity of tanshinone IIA in combined with cyclophosphamide against Lewis mice with lung cancer

Qi Li et al.

ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2016)